Acadia Healthcare's (ACHC) revised long-term growth targets are "reasonable" as they reflect the longer ramp of new facilities, RBC Capital Markets said in a Tuesday note.
The company provided additional commentary on its revised long-term outlook, saying that the lower-than-expected earnings before interest, taxes, depreciation, and amortization was mainly related to the longer ramp of new facilities compared to expansion beds, RBC analysts noted.
Acadia management also pointed out conservatism related to rate growth assumptions, given uncertainty surrounding policy and the macro environment, the analysts said.
The analysts said the company's clarifications "comprise a reasonable basis" for the revised long-term outlook.
RBC maintained its outperform rating and $43 price target on the stock.
Price: 23.04, Change: -0.48, Percent Change: -2.04
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。